132 related articles for article (PubMed ID: 29295878)
41. Comorbidities, Rather Than Older Age, Are Strongly Associated With Higher Utilization of Healthcare in Colorectal Cancer Survivors.
Thong MSY; Boakye D; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H; Arndt V
J Natl Compr Canc Netw; 2021 Dec; 20(5):468-478.e7. PubMed ID: 34875626
[TBL] [Abstract][Full Text] [Related]
42. Colorectal cancer among Indigenous and non-Indigenous people in Queensland, Australia: Toward survival equality.
Moore SP; Green AC; Bray F; Coory M; Garvey G; Sabesan S; Valery PC
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e209-14. PubMed ID: 24571285
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
[TBL] [Abstract][Full Text] [Related]
44. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
45. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival.
Helewa RM; Turner D; Park J; Wirtzfeld D; Czaykowski P; Hochman D; Singh H; Shu E; McKay A
J Surg Oncol; 2013 Nov; 108(6):378-84. PubMed ID: 24037666
[TBL] [Abstract][Full Text] [Related]
46. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis.
Gheybi K; Buckley E; Vitry A; Roder D
Cancer Epidemiol; 2022 Oct; 80():102246. PubMed ID: 36067574
[TBL] [Abstract][Full Text] [Related]
47. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study.
Michalopoulou E; Matthes KL; Karavasiloglou N; Wanner M; Limam M; Korol D; Held L; Rohrmann S
Cancer Epidemiol; 2021 Aug; 73():101962. PubMed ID: 34051687
[TBL] [Abstract][Full Text] [Related]
48. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
[TBL] [Abstract][Full Text] [Related]
49. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
[TBL] [Abstract][Full Text] [Related]
50. Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy?
Ahmed S; Pahwa P; Fields A; Chandra-Kanthan S; Iqbal N; Zaidi A; Reeder B; Plaza FA; Zhu T; Leis A
Oncology; 2015; 88(5):289-97. PubMed ID: 25592112
[TBL] [Abstract][Full Text] [Related]
51. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer.
Chiao EY; Nambi PV; Naik AD
J Cancer Surviv; 2010 Dec; 4(4):381-7. PubMed ID: 20721633
[TBL] [Abstract][Full Text] [Related]
52. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer.
Truong PT; Kader HA; Lacy B; Lesperance M; MacNeil MV; Berthelet E; McMurtrie E; Alexander S
Am J Clin Oncol; 2005 Apr; 28(2):157-64. PubMed ID: 15803010
[TBL] [Abstract][Full Text] [Related]
53. Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study.
Lee YH; Kung PT; Wang YH; Kuo WY; Kao SL; Tsai WC
PLoS One; 2019; 14(1):e0210465. PubMed ID: 30640932
[TBL] [Abstract][Full Text] [Related]
54. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.
Yamano T; Yamauchi S; Kimura K; Babaya A; Hamanaka M; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Tomita N; Sugihara K;
Eur J Cancer; 2017 Aug; 81():90-101. PubMed ID: 28622612
[TBL] [Abstract][Full Text] [Related]
55. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma.
Ouellette JR; Small DG; Termuhlen PM
J Gastrointest Surg; 2004 Dec; 8(8):1061-7. PubMed ID: 15585394
[TBL] [Abstract][Full Text] [Related]
58. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
[TBL] [Abstract][Full Text] [Related]
59. The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.
Arkenbosch JHC; van Erning FN; Rutten HJ; Zimmerman D; de Wilt JHW; Beijer S
Eur J Surg Oncol; 2019 Feb; 45(2):160-166. PubMed ID: 30712552
[TBL] [Abstract][Full Text] [Related]
60. Time to diagnosis and stage of symptomatic colorectal cancer determined by three different sources of information: A population based retrospective study.
Leiva A; Esteva M; Llobera J; Macià F; Pita-Fernández S; González-Luján L; Sánchez-Calavera MA; Ramos M
Cancer Epidemiol; 2017 Apr; 47():48-55. PubMed ID: 28126583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
